Ocumension Therapeutics (1477.HK)

HKD 5.44

(0.37%)

Inventory Summary of Ocumension Therapeutics

Ocumension Therapeutics's latest annual inventory in 2023 was 32.47 Million CNY , up 34.72% from previous year.
Ocumension Therapeutics's latest quarterly inventory in 2023 FY was 32.47 Million CNY , up 34.72% from previous quarter.
Ocumension Therapeutics reported annual inventory of 24.1 Million CNY in 2022, up 382.76% from previous year.
Ocumension Therapeutics reported annual inventory of 4.99 Million CNY in 2021, up 64.95% from previous year.
Ocumension Therapeutics reported quarterly inventory of 32.47 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Ocumension Therapeutics reported quarterly inventory of 28.91 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of Ocumension Therapeutics (2023 - 2018)

Historical Annual Inventory of Ocumension Therapeutics (2023 - 2018)

Year	Inventory	Inventory Growth
2023	32.47 Million CNY	34.72%
2022	24.1 Million CNY	382.76%
2021	4.99 Million CNY	64.95%
2020	3.02 Million CNY	1068.73%
2019	259 Thousand CNY	0.0%
2018	- CNY	0.0%

Year	Inventory	Inventory Growth
2023 Q1	28.91 Million CNY	19.95%
2023 Q4	32.47 Million CNY	0.0%
2023 Q2	28.91 Million CNY	0.0%
2023 Q3	32.47 Million CNY	12.32%
2023 FY	32.47 Million CNY	34.72%
2022 Q1	23.82 Million CNY	377.11%
2022 Q4	24.1 Million CNY	0.0%
2022 Q3	24.1 Million CNY	1.18%
2022 Q2	23.82 Million CNY	0.0%
2022 FY	24.1 Million CNY	382.76%
2021 Q1	2.3 Million CNY	-23.72%
2021 FY	4.99 Million CNY	64.95%
2021 Q3	4.99 Million CNY	116.24%
2021 Q2	2.3 Million CNY	0.0%
2021 Q4	4.99 Million CNY	0.0%
2020 Q3	3.02 Million CNY	1177.22%
2020 Q4	3.02 Million CNY	0.0%
2020 FY	3.02 Million CNY	1068.73%
2020 Q1	237 Thousand CNY	-8.49%
2020 Q2	237 Thousand CNY	0.0%
2019 Q1	- CNY	0.0%
2019 Q4	259 Thousand CNY	0.0%
2019 Q3	259 Thousand CNY	0.0%
2019 FY	259 Thousand CNY	0.0%
2018 FY	- CNY	0.0%

Peer Inventory Comparison of Ocumension Therapeutics

Name	Inventory	Inventory Difference
Uni-Bio Science Group Limited	36.39 Million HKD	10.769%
CK Life Sciences Int'l., (Holdings) Inc.	1.2 Billion HKD	97.304%